A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the eastern cooperative oncology group study E2200

Bruce J. Giantonio, Al B. Benson, P J O’Dwyer et al.|Annals of Oncology|2006

Cited by 135